These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26978505)

  • 21. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
    Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.
    Hatano T; Okuzumi A; Kamagata K; Daida K; Taniguchi D; Hori M; Yoshino H; Aoki S; Hattori N
    J Neural Transm (Vienna); 2017 Apr; 124(4):407-415. PubMed ID: 28160151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
    Dave KD; De Silva S; Sheth NP; Ramboz S; Beck MJ; Quang C; Switzer RC; Ahmad SO; Sunkin SM; Walker D; Cui X; Fisher DA; McCoy AM; Gamber K; Ding X; Goldberg MS; Benkovic SA; Haupt M; Baptista MA; Fiske BK; Sherer TB; Frasier MA
    Neurobiol Dis; 2014 Oct; 70():190-203. PubMed ID: 24969022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
    Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
    Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permanent expression of midbrain dopaminergic neurons traits in differentiated amniotic epithelial cells.
    Niknejad H; Deihim T; Ahmadiani A; Jorjani M; Peirovi H
    Neurosci Lett; 2012 Jan; 506(1):22-7. PubMed ID: 22037229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral function of bone marrow multipotent adult progenitor cells after transplantation in Parkinson's disease rat models.
    Zhang N; Zhou H; Wang H; Yu L; Li Z; Xu H; Wang M
    Transplant Proc; 2013 Mar; 45(2):719-25. PubMed ID: 23498812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
    Lin CH; Huang JY; Ching CH; Chuang JI
    J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Parkin in the Neuronal Progenitor Cells from a Patient with Parkinson's Disease Shifts the Transcriptome Towards the Normal State.
    Lebedeva O; Poberezhniy D; Novosadova E; Gerasimova T; Novosadova L; Arsenyeva E; Stepanenko E; Shimchenko D; Volovikov E; Anufrieva K; Illarioshkin S; Lagarkova M; Grivennikov I; Tarantul V; Nenasheva V
    Mol Neurobiol; 2023 Jun; 60(6):3522-3533. PubMed ID: 36884134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
    Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
    Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine dopaminergic Müller cells restore motor function in a model of Parkinson's disease.
    Stutz B; da Conceição FS; Santos LE; Cadilhe DV; Fleming RL; Acquarone M; Gardino PF; de Melo Reis RA; Dickson PW; Dunkley PR; Rehen S; Houzel JC; de Mello FG
    J Neurochem; 2014 Mar; 128(6):829-40. PubMed ID: 24117434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
    Wersinger C; Sidhu A
    Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties.
    Li X; Qi J; Yamaguchi T; Wang HL; Morales M
    Brain Struct Funct; 2013 Sep; 218(5):1159-76. PubMed ID: 22926514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel dopamine transporter transgenic mouse line for identification and purification of midbrain dopaminergic neurons reveals midbrain heterogeneity.
    Apuschkin M; Stilling S; Rahbek-Clemmensen T; Sørensen G; Fortin G; Herborg Hansen F; Eriksen J; Trudeau LE; Egerod K; Gether U; Rickhag M
    Eur J Neurosci; 2015 Oct; 42(7):2438-54. PubMed ID: 26286107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
    Arias RL; Sung ML; Vasylyev D; Zhang MY; Albinson K; Kubek K; Kagan N; Beyer C; Lin Q; Dwyer JM; Zaleska MM; Bowlby MR; Dunlop J; Monaghan M
    Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of Functional Dopaminergic Neurons from Reprogramming Fibroblasts by Nonviral-based Mesoporous Silica Nanoparticles.
    Chang JH; Tsai PH; Wang KY; Wei YT; Chiou SH; Mou CY
    Sci Rep; 2018 Jan; 8(1):11. PubMed ID: 29311646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.